Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma

Surgical liver resection is a treatment option in patients with resectable colorectal liver metastases. We present two cases of focal nodular hyperplasia (FNH) development after treatment with oxaliplatin during follow-up of colon carcinoma. The first case was a 40-year-old male patient who develope...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. de Wert, S. A. Huisman, F. Imani, D. J. de Gooyer, J. M. G. H. van Riel, P. D. Gobardhan, A. M. Rijken
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Surgery
Online Access:http://dx.doi.org/10.1155/2021/6676109
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850230129252368384
author L. A. de Wert
S. A. Huisman
F. Imani
D. J. de Gooyer
J. M. G. H. van Riel
P. D. Gobardhan
A. M. Rijken
author_facet L. A. de Wert
S. A. Huisman
F. Imani
D. J. de Gooyer
J. M. G. H. van Riel
P. D. Gobardhan
A. M. Rijken
author_sort L. A. de Wert
collection DOAJ
description Surgical liver resection is a treatment option in patients with resectable colorectal liver metastases. We present two cases of focal nodular hyperplasia (FNH) development after treatment with oxaliplatin during follow-up of colon carcinoma. The first case was a 40-year-old male patient who developed multiple liver lesions suspect for metastatic disease four years after he had undergone laparoscopic right-sided hemicolectomy and adjuvant chemotherapy (capecitabine and oxaliplatin). He underwent a metastasectomy of segments three and four and microwave ablation (MWA) of the lesion in segment one. Pathological analysis demonstrated FNH. The second patient was a 21-year-old woman who presented with multiple liver lesions during follow-up for colon carcinoma. She underwent a laparoscopic right-sided hemicolectomy and was adjuvantly treated with capecitabine and oxaliplatin three years ago. Magnetic resonance imaging (MRI) was performed, and the lesions showed no signs of metastatic disease but were classified as FNH. Therefore, the decision was made to follow up the patient. In conclusion, the development of benign liver lesions could occur during follow-up of colon carcinoma and might be caused by oxaliplatin-induced changes to the liver parenchyma. Hence, it is important to distinguish these from metastatic liver disease.
format Article
id doaj-art-2a05572cb7c64c7f80cb58338d6777db
institution OA Journals
issn 2090-6900
2090-6919
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Case Reports in Surgery
spelling doaj-art-2a05572cb7c64c7f80cb58338d6777db2025-08-20T02:03:58ZengWileyCase Reports in Surgery2090-69002090-69192021-01-01202110.1155/2021/66761096676109Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon CarcinomaL. A. de Wert0S. A. Huisman1F. Imani2D. J. de Gooyer3J. M. G. H. van Riel4P. D. Gobardhan5A. M. Rijken6Department of Surgery, Amphia Hospital, Breda, NetherlandsDepartment of Surgery, Amphia Hospital, Breda, NetherlandsDepartment of Radiology, Amphia Hospital, Breda, NetherlandsDepartment of Oncology, Bravis Hospital, Roosendaal/Bergen op Zoom, NetherlandsDepartment of Oncology, ETZ Elisabeth Hospital, Tilburg, NetherlandsDepartment of Surgery, Amphia Hospital, Breda, NetherlandsDepartment of Surgery, Amphia Hospital, Breda, NetherlandsSurgical liver resection is a treatment option in patients with resectable colorectal liver metastases. We present two cases of focal nodular hyperplasia (FNH) development after treatment with oxaliplatin during follow-up of colon carcinoma. The first case was a 40-year-old male patient who developed multiple liver lesions suspect for metastatic disease four years after he had undergone laparoscopic right-sided hemicolectomy and adjuvant chemotherapy (capecitabine and oxaliplatin). He underwent a metastasectomy of segments three and four and microwave ablation (MWA) of the lesion in segment one. Pathological analysis demonstrated FNH. The second patient was a 21-year-old woman who presented with multiple liver lesions during follow-up for colon carcinoma. She underwent a laparoscopic right-sided hemicolectomy and was adjuvantly treated with capecitabine and oxaliplatin three years ago. Magnetic resonance imaging (MRI) was performed, and the lesions showed no signs of metastatic disease but were classified as FNH. Therefore, the decision was made to follow up the patient. In conclusion, the development of benign liver lesions could occur during follow-up of colon carcinoma and might be caused by oxaliplatin-induced changes to the liver parenchyma. Hence, it is important to distinguish these from metastatic liver disease.http://dx.doi.org/10.1155/2021/6676109
spellingShingle L. A. de Wert
S. A. Huisman
F. Imani
D. J. de Gooyer
J. M. G. H. van Riel
P. D. Gobardhan
A. M. Rijken
Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
Case Reports in Surgery
title Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
title_full Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
title_fullStr Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
title_full_unstemmed Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
title_short Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
title_sort appearance of focal nodular hyperplasia after chemotherapy in two patients during follow up of colon carcinoma
url http://dx.doi.org/10.1155/2021/6676109
work_keys_str_mv AT ladewert appearanceoffocalnodularhyperplasiaafterchemotherapyintwopatientsduringfollowupofcoloncarcinoma
AT sahuisman appearanceoffocalnodularhyperplasiaafterchemotherapyintwopatientsduringfollowupofcoloncarcinoma
AT fimani appearanceoffocalnodularhyperplasiaafterchemotherapyintwopatientsduringfollowupofcoloncarcinoma
AT djdegooyer appearanceoffocalnodularhyperplasiaafterchemotherapyintwopatientsduringfollowupofcoloncarcinoma
AT jmghvanriel appearanceoffocalnodularhyperplasiaafterchemotherapyintwopatientsduringfollowupofcoloncarcinoma
AT pdgobardhan appearanceoffocalnodularhyperplasiaafterchemotherapyintwopatientsduringfollowupofcoloncarcinoma
AT amrijken appearanceoffocalnodularhyperplasiaafterchemotherapyintwopatientsduringfollowupofcoloncarcinoma